Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker VRCA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 12, 2026 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 6, 2026 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 9, 2026 | VRCA Verrica Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 9, 2026 | VRCA Verrica Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 12, 2026 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Mar 11, 2026 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 30, 2025 | VRCA Verrica Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 24, 2025 | VRCA Verrica Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 24, 2025 | VRCA Verrica Pharmaceuticals Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Nov 24, 2025 | VRCA Verrica Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 14, 2025 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 12, 2025 | VRCA Verrica Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 12, 2025 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 30, 2025 | VRCA Verrica Pharmaceuticals Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Jul 23, 2025 | VRCA Verrica Pharmaceuticals Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Jul 1, 2025 | VRCA Verrica Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 1, 2025 | VRCA Verrica Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 12, 2025 | VRCA Verrica Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 5, 2025 | VRCA Verrica Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 25, 2025 | VRCA Verrica Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Apr 2, 2025 | VRCA Verrica Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Mar 11, 2025 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 21, 2025 | VRCA Verrica Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 30, 2025 | VRCA Verrica Pharmaceuticals Inc. | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule | 8-K | 8-K ↗ |
| Dec 9, 2024 | VRCA Verrica Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 21, 2024 | VRCA Verrica Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 21, 2024 | VRCA Verrica Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 20, 2024 | VRCA Verrica Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 4, 2024 | VRCA Verrica Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Nov 4, 2024 | VRCA Verrica Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
31 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:11 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances